论文部分内容阅读
目的探究乙酰谷酰胺联合白蛋白治疗脑栓塞所致脑梗死的临床应用。方法 90例脑栓塞所致脑梗死患者,随机分为对照组和观察组,每组45例。对照组使用常规治疗,观察组采用乙酰谷酰胺联合白蛋白治疗,比较两组的临床疗效。结果观察组患者经治疗后总有效率为86.7%,神经功能缺损评分(11.70±6.48)分;对照组患者经治疗后的总有效率为51.1%,神经功能缺损评分(18.75±9.23)分,两组各项指标比较差异均有统计学意义(P<0.05)。结论乙酰谷酰胺联合白蛋白治疗脑栓塞所致脑梗死,其临床疗效确切有效,值得在临床上推广应用。
Objective To investigate the clinical application of acetylglutamine combined with albumin in the treatment of cerebral infarction caused by cerebral embolism. Methods 90 patients with cerebral infarction caused by cerebral embolism were randomly divided into control group and observation group, 45 cases in each group. The control group was treated with conventional therapy. The observation group was treated with acetylglutamine combined with albumin. The clinical efficacy was compared between the two groups. Results The total effective rate of the observation group was 86.7% and the neurological deficit score was 11.70 ± 6.48. The total effective rate of the control group after treatment was 51.1% and the score of neurological deficit was 18.75 ± 9.23, The differences between the two groups were statistically significant (P <0.05). Conclusion Acetylglutamine combined with albumin in the treatment of cerebral infarction caused by cerebral embolism, the clinical curative effect is accurate and effective, which is worth popularizing in clinic.